Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 625 of 6351
-
Could fixing sleep before knee surgery cut Long-Term pain?
Symptom relief Recruiting nowThis research study is being done to compare different methods of addressing sleep problems before total knee replacement surgery. These methods include Cognitive Behavioral Therapy and light exposure.
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Brain zaps could predict who gets relief from stubborn depression
Symptom relief By invitation onlyThe primary aim of the study is to find the combination of neuroimaging-related markers, demographics, and clinical characteristics that predict the response of patients with therapy-resistant depression to theta-burst rTMS treatment. The secondary aim is to monitor the cognitive…
Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
CBD shows promise in opioid recovery: major trial underway
Disease control Recruiting nowThe long-term goal of the project is to determine whether cannabidiol (CBD) can reduce craving and relapse in individuals with opioid use disorder (OUD). The first phase of this project was an open cross-over design study in healthy individuals to confirm the safety and pharmacok…
Phase 3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug KarXT aims to tame bipolar mania in major trial
Symptom relief Recruiting nowThis is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features. The primary objective of the study is to evaluate the efficacy of KarXT compar…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could a single infusion of 'Peacekeeper' cells let kidney transplant patients ditch most of their meds?
Disease control Recruiting nowThe goal of this multi-national, multi-center, open-label, randomized Phase 2 trial is to determine the safety and efficacy of administering expanded regulatory T cells (TRK-001) to prevent allograft rejection in living donor renal transplant recipients. Enrolled subjects will b…
Phase 2 • Sponsor: Singulera Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study targets lung cancer in black patients: can immunotherapy improve outcomes?
Disease control Recruiting nowThis is a non-registrational, cohort study enrolling eligible Black patients diagnosed with histologically or cytologically, advanced/metastatic NSCLC without known EGFR/ALK/ROS1 tumor mutations, and who are ≥ 18 years of age, ECOG performance status 0-2, and may have detectable …
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug combo aims to boost chemo for tough pancreatic cancer
Disease control Recruiting nowThe investigators hypothesize that MK2 inhibition may improve efficacy of mFOLFIRINOX chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC).
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for liver cancer: targeted drug ABSK-011 enters phase 2 trial
Disease control Recruiting nowThis is a randomized, double-blind, multicenter, Phase 2 study to evaluate the efficacy and safety of ABSK-011 plus BSC versus placebo plus BSC in advanced or unresectable hepatocellular carcinoma (HCC) patients with FGF19 overexpression who have received prior systemic therapy. …
Phase 2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New antibody drug aims to stop lung cancer relapse in its tracks
Disease control Recruiting nowThis is a randomized, double-blind, phase III clinical study to compare the efficacy and safety of AK112 to placebo as consolidation treatment for patients with limited stage small cell lung cancer who have not progressed following concurrent chemoradiation therapy.
Phase 3 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Heart drug may shield tiny babies from deadly Post-Surgery syndrome
Prevention Recruiting nowThe goal of this Phase 3, randomized, masked clinical trial is to is to find out whether milrinone, when given to infants after PDA closure, will help the heart work better by supplying oxygen to the lungs and tissues. The main questions it aims to answer are: 1. to determine i…
Phase 3 • Sponsor: NICHD Neonatal Research Network • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Nicotine pouches vs. patches: can they help appalachian smokers quit cigarettes and cut cancer risk?
Disease control Recruiting nowThis clinical trial compares the use of oral nicotine pouches to nicotine replacement therapy, consisting of nicotine patches and lozenges, to reduce cigarette use in smokers living in rural Appalachia. The lung and oral cancers that plague Appalachia are fueled by cigarette smok…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Psychedelics take on alcoholism: psilocybin vs ketamine in new trial
Disease control Recruiting nowThis study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will …
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy aims to boost remission in rare blood cancer
Disease control Recruiting nowThis phase II MyeloMATCH treatment trial compares the usual treatment of cedazuridine-decitabine (ASTX727) to the combination treatment of ASTX727 and enasidenib in treating patients with higher-risk, IDH2-mutated myelodysplastic syndrome (MDS). ASTX727 is a combination of two dr…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for tough prostate cancer: Immune-Engaging drug enters human trials
Disease control Recruiting nowThe goal of the study is to evaluate how safe and how well the body handles GSK5458514 when administered in participants with prostate cancer. The study will be conducted in two parts - Part 1 (dose escalation phase) and Part 2 (dose expansion phase).
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for young cancer patients: drug duo targets tough tumors
Disease control PausedThis phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolescents and young adults with solid tumors and fibrolamellar cancer that has come back after a period of improvement (relaps…
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Lung cancer screening on wheels: can mobile vans save more lives?
Prevention Recruiting nowLung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current …
Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 26, 2026 15:10 UTC
-
New cream could ease painful skin bumps for HS sufferers
Symptom relief OngoingThe purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
Phase 3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New blood test could speed up stroke diagnosis and save lives
Diagnosis Recruiting nowIntracerebral hemorrhage carries high rates of mortality and disability, imposes a significant societal burden. Based on findings from our previous multicenter randomized controlled clinical trial (INTERACT4), we revealed that initiating intensive blood pressure reduction therapy…
Sponsor: Shanghai East Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Jail-Based hep c cure program shows promise in pilot study
Cure Recruiting nowThe goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more easily. This study focuses on adults at the Rhode Island Department of Corrections who have active HC…
Phase 4 • Sponsor: Lifespan • Aim: Cure
Last updated Jun 27, 2026 09:09 UTC
-
New drug could ease painful muscle condition and cut steroid use
Disease control OngoingThe primary objective of the study is to evaluate the efficacy of olokizumab (OKZ) 64 mg administered subcutaneously every 2 weeks compared with placebo in participants with polymyalgia rheumatica (PMR). The secondary objectives are to evaluate the steroid-sparing effect, inflamm…
Phase 3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC